UniProt ID | TEX10_HUMAN | |
---|---|---|
UniProt AC | Q9NXF1 | |
Protein Name | Testis-expressed protein 10 | |
Gene Name | TEX10 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 929 | |
Subcellular Localization | Nucleus, nucleoplasm . Cytoplasm . Nucleus, nucleolus . Mainly found in the nucleoplasm, with low levels detected in the cytoplasmic and chromatin fractions. | |
Protein Description | Functions as a component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes. [PubMed: 22872859 Component of the PELP1 complex involved in the nucleolar steps of 28S rRNA maturation and the subsequent nucleoplasmic transit of the pre-60S ribosomal subunit] | |
Protein Sequence | MTKKRKRQHDFQKVKLKVGKKKPKLQNATPTNFKTKTIHLPEQLKEDGTLPTNNRKLNIKDLLSQMHHYNAGVKQSALLGLKDLLSQYPFIIDAHLSNILSEVTAVFTDKDANVRLAAVQLLQFLAPKIRAEQISPFFPLVSAHLSSAMTHITEGIQEDSLKVLDILLEQYPALITGRSSILLKNFVELISHQQLSKGLINRDRSQSWILSVNPNRRLTSQQWRLKVLVRLSKFLQALADGSSRLRESEGLQEQKENPHATSNSIFINWKEHANDQQHIQVYENGGSQPNVSSQFRLRYLVGGLSGVDEGLSSTENLKGFIEIIIPLLIECWVEAVPPQLATPVGNGIEREPLQVMQQVLNIISLLWKLSKQQDETHKLESWLRKNYLIDFKHHFMSRFPYVLKEITKHKRKEPNKSIKHCTVLSNNIDHLLLNLTLSDIMVSLANASTLQKDCSWIEMIRKFVTETLEDGSRLNSKQLNRLLGVSWRLMQIQPNREDTETLIKAVYTLYQQRGLILPVRTLLLKFFSKIYQTEELRSCRFRYRSKVLSRWLAGLPLQLAHLGSRNPELSTQLIDIIHTAAARANKELLKSLQATALRIYDPQEGAVVVLPADSQQRLVQLVYFLPSLPADLLSRLSRCCIMGRLSSSLAAMLIGILHMRSSFSGWKYSAKDWLMSDVDYFSFLFSTLTGFSKEELTWLQSLRGVPHVIQTQLSPVLLYLTDLDQFLHHWDVTEAVFHSLLVIPARSQNFDILQSAISKHLVGLTVIPDSTAGCVFGVICKLLDHTCVVSETLLPFLASCCYSLLYFLLTIEKGEAEHLRKRDKLWGVCVSILALLPRVLRLMLQSLRVNRVGPEELPVVGQLLRLLLQHAPLRTHMLTNAILVQQIIKNITTLKSGSVQEQWLTDLHYCFNVYITGHPQGPSALATVY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
20 | Acetylation | KVKLKVGKKKPKLQN HCCCCCCCCCCCCCC | 61.69 | 26051181 | |
21 | Acetylation | VKLKVGKKKPKLQNA CCCCCCCCCCCCCCC | 69.27 | 26051181 | |
24 | Acetylation | KVGKKKPKLQNATPT CCCCCCCCCCCCCCC | 72.14 | 26051181 | |
29 | Phosphorylation | KPKLQNATPTNFKTK CCCCCCCCCCCCCCC | 37.89 | 29255136 | |
31 | O-linked_Glycosylation | KLQNATPTNFKTKTI CCCCCCCCCCCCCEE | 49.27 | 30379171 | |
31 | Phosphorylation | KLQNATPTNFKTKTI CCCCCCCCCCCCCEE | 49.27 | 19664994 | |
34 | Ubiquitination | NATPTNFKTKTIHLP CCCCCCCCCCEECCC | 51.70 | - | |
34 | Methylation | NATPTNFKTKTIHLP CCCCCCCCCCEECCC | 51.70 | 115980007 | |
36 | Methylation | TPTNFKTKTIHLPEQ CCCCCCCCEECCCHH | 46.18 | 115980013 | |
36 | Ubiquitination | TPTNFKTKTIHLPEQ CCCCCCCCEECCCHH | 46.18 | - | |
37 | Phosphorylation | PTNFKTKTIHLPEQL CCCCCCCEECCCHHH | 20.89 | 28555341 | |
45 | Ubiquitination | IHLPEQLKEDGTLPT ECCCHHHCCCCCCCC | 54.15 | - | |
45 | Acetylation | IHLPEQLKEDGTLPT ECCCHHHCCCCCCCC | 54.15 | 26051181 | |
49 | Phosphorylation | EQLKEDGTLPTNNRK HHHCCCCCCCCCCCC | 41.72 | 25159151 | |
52 | Phosphorylation | KEDGTLPTNNRKLNI CCCCCCCCCCCCCCH | 48.52 | 25159151 | |
64 | Phosphorylation | LNIKDLLSQMHHYNA CCHHHHHHHHHHHCH | 32.52 | 23401153 | |
76 | Phosphorylation | YNAGVKQSALLGLKD HCHHHHHHHHHCHHH | 18.37 | 21406692 | |
196 | Phosphorylation | LISHQQLSKGLINRD HHCHHHHHCCCCCCC | 21.97 | - | |
197 | Acetylation | ISHQQLSKGLINRDR HCHHHHHCCCCCCCC | 67.35 | 26051181 | |
197 | Ubiquitination | ISHQQLSKGLINRDR HCHHHHHCCCCCCCC | 67.35 | 21890473 | |
200 | Ubiquitination | QQLSKGLINRDRSQS HHHHCCCCCCCCCCC | 5.61 | 21890473 | |
205 | Phosphorylation | GLINRDRSQSWILSV CCCCCCCCCCEEEEE | 32.62 | 22210691 | |
207 | Phosphorylation | INRDRSQSWILSVNP CCCCCCCCEEEEECC | 19.82 | 28555341 | |
220 | Phosphorylation | NPNRRLTSQQWRLKV CCCCCCCCHHHHHHH | 25.60 | 22210691 | |
233 | Acetylation | KVLVRLSKFLQALAD HHHHHHHHHHHHHHH | 55.47 | 26051181 | |
305 | Phosphorylation | RYLVGGLSGVDEGLS HHHHCCCCCCCCCCC | 39.79 | - | |
312 | Phosphorylation | SGVDEGLSSTENLKG CCCCCCCCCCCCHHH | 46.18 | - | |
378 | Ubiquitination | KQQDETHKLESWLRK HCCCCHHHHHHHHHH | 62.46 | - | |
385 | Acetylation | KLESWLRKNYLIDFK HHHHHHHHCCCHHHH | 48.01 | 26051181 | |
385 | Malonylation | KLESWLRKNYLIDFK HHHHHHHHCCCHHHH | 48.01 | 26320211 | |
392 | Acetylation | KNYLIDFKHHFMSRF HCCCHHHHHHHHHHC | 32.21 | 25953088 | |
404 | Ubiquitination | SRFPYVLKEITKHKR HHCHHHHHHHHHCCC | 36.71 | - | |
462 | Acetylation | SWIEMIRKFVTETLE HHHHHHHHHHHHHCC | 33.01 | 26051181 | |
462 | Ubiquitination | SWIEMIRKFVTETLE HHHHHHHHHHHHHCC | 33.01 | - | |
525 | Acetylation | PVRTLLLKFFSKIYQ HHHHHHHHHHHHHHC | 44.31 | 26051181 | |
529 | Acetylation | LLLKFFSKIYQTEEL HHHHHHHHHHCCHHH | 40.03 | 25825284 | |
529 | Ubiquitination | LLLKFFSKIYQTEEL HHHHHHHHHHCCHHH | 40.03 | - | |
531 | Phosphorylation | LKFFSKIYQTEELRS HHHHHHHHCCHHHHH | 17.08 | 25690035 | |
533 | Phosphorylation | FFSKIYQTEELRSCR HHHHHHCCHHHHHCC | 17.92 | 25690035 | |
590 | Ubiquitination | RANKELLKSLQATAL HCCHHHHHHHHHHHH | 62.84 | 21890473 | |
623 | Phosphorylation | QRLVQLVYFLPSLPA HHHHHHHHHCCCCCH | 14.16 | 22817900 | |
846 | Phosphorylation | VLRLMLQSLRVNRVG HHHHHHHHHCCCCCC | 17.74 | 21406692 | |
873 | Acetylation | LLLQHAPLRTHMLTN HHHHCCCHHHHHHHH | 11.64 | 19608861 | |
889 | Acetylation | ILVQQIIKNITTLKS HHHHHHHHHCCCCCC | 43.88 | 19608861 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TEX10_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TEX10_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TEX10_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
GNL3_HUMAN | GNL3 | physical | 26344197 | |
NOL9_HUMAN | NOL9 | physical | 26344197 | |
PELP1_HUMAN | PELP1 | physical | 26344197 | |
SENP3_HUMAN | SENP3 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-889, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-29, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-29, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-31, AND MASSSPECTROMETRY. |